Ignite Creation Date:
2025-12-25 @ 2:41 AM
Ignite Modification Date:
2025-12-29 @ 3:41 AM
Study NCT ID:
NCT05344833
Status:
RECRUITING
Last Update Posted:
2025-08-06
First Post:
2022-04-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Post-Autologous Transplant Maintenance With Isatuximab and Lenalidomide in Minimal Residual Disease Positive Multiple Myeloma
Sponsor:
University of Illinois at Chicago
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-01-05
Start Date Type:
ACTUAL
Primary Completion Date:
2030-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-12
Completion Date Type:
ESTIMATED
First Submit Date:
2022-04-19
First Submit QC Date:
None
Study First Post Date:
2022-04-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-31
Last Update Post Date:
2025-08-06
Last Update Post Date Type:
ACTUAL